Emily Edson‐Heredia

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

Craig L. Leonardi, Robert Matheson, Claus Zachariae et al. · New England Journal of Medicine · 2012 · 927 citations · Full text

Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study

Brett King, Justin Ko, Seth Forman et al. · Journal of the American Academy of Dermatology · 2021 · 111 citations · Full text

Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis

Jina Chung, Kristina Callis Duffin, Junko Takeshita et al. · Journal of the American Academy of Dermatology · 2014 · 107 citations · Full text

Palmoplantar Psoriasis, Autoimmune Disease, Health-related Quality +5

Efficacy and safety of ixekizumab in a phase <scp>III</scp> , randomized, double‐blind, placebo‐controlled study in paediatric patients with moderate‐to‐severe plaque psoriasis ( <scp>IXORA</scp> ‐ <scp>PEDS</scp> )

Amy S. Paller, Marieke M.B. Seyger, Gabriel A. Magariños et al. · British Journal of Dermatology · 2020 · 102 citations · Full text

Development of a Disease-Specific Version of the EQ-5D-5L for Use in Patients Suffering from Psoriasis: Lessons Learned from a Feasibility Study in the UK

Paul Swinburn, Andrew Lloyd, Kristina S. Boye et al. · Value in Health · 2013 · 98 citations

Autoimmune Disease, Disease-specific Version, Medicine +6